Ignite Creation Date:
2024-07-17 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06469307
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-06-17
Brief Title:
Driving Inclusivity Validity and Equity in Research Through Strategic Engagement DIVERSE
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Study Overview
Official Title:
Driving Inclusivity Validity and Equity in Research Through Strategic Engagement DIVERSE
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DIVERSE
Brief Summary:
The purpose of this research study is to enhance inclusion and diversity in clinical trial enrollment by training participants to perform and provide feedback through a community-based protocol review process called DIVERSE
Detailed Description:
This research study aims to pilot a protocol review process called DIVERSE assessing its feasibility acceptability and preliminary efficacy to enhance inclusion and diversity in clinical trial enrollment Patients and community participants will complete specialized training and provide feedback on clinical trials in development through the DIVERSE process they will also provide feedback on the process itself Investigator participants will request review and provide feedback on the DIVERSE process The study is based on community-based participatory research
Participation in this research is expected to last about 18 months It is expected that about 20 patient and community participants and 20 investigators will participate in this research study The National Cancer Institute and American Society of Clinical Oncology are providing funding for this research study
Participation in this research is expected to last about 18 months It is expected that about 20 patient and community participants and 20 investigators will participate in this research study The National Cancer Institute and American Society of Clinical Oncology are providing funding for this research study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| K08CA273043 | NIH | None | None |